Montelukast Prescribing at PARK HOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
355
Total Quantity
12.2K
NHS Cost
£573
vs National Avg
-48.2%
PARK HOUSE SURGERY prescribed 355 items of Montelukast over the last 12 months at a cost of £573 to the NHS. This is 48.2% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
30
Jul 2026
29
Jul 2026
38
Jul 2026
32
Jul 2026
27
Jul 2026
26
Jul 2026
36
Jul 2026
27
Jul 2026
26
Jul 2026
28
Jul 2026
26
Jul 2026
30
Prescribing Details
| Total Items | 355 |
|---|---|
| Total Quantity | 12,152 |
| Total NHS Cost | £573 |
| Presentations | 3 different forms |
| vs National Average | -48.2% |
Montelukast Prescribing Comparison
| This practice | 355 items |
|---|---|
| National average per practice | 685 items |
| Difference | -48.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.